Hilo de navegación
Oncología hepática (BCLC)
Publicaciones destacadas
-
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort
Moon, AM; Yanagihara, TK; Dawson, LA; Yu, JI; Lawrence, TS;(...)Tan, XM; Molla, M; Tepper, JE; Torres, F; Reig, M.Referencia:JOURNAL OF CLINICAL ONCOLOGY 2026.
-
BCLC classification and AI-based image quantification: What is meant to be will come together-but how and when?
Muller, Lukas; Kather, Jakob N; Marquardt, Jens U; Reig, Maria; Wang, Qiang;dos Santos, Daniel Pinto; Kloeckner, Roman.Referencia:JOURNAL OF HEPATOLOGY 2026.
-
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
Reig, M; Sanduzzi-Zamparelli, M; Forner, A; Rimola, J; Ferrer-Fàbrega, J;(...)Vogel, A; Yanagihara, TK; Ayuso, C; Torres, F; Bruix, J.Referencia:JOURNAL OF HEPATOLOGY 2026.
-
Reproducibility and accuracy of non-contrast abbreviated magnetic resonance imaging of the liver in surveillance for early recurrence for hepatocellular carcinoma in a Western population: a multi-reader study
Rimola, Jordi; Saborido, Belen; Igual, Alba; Roca, Andreu; Darnell, Anna;(...)Mesa, Alicia; Navarro, Vicente; Soler, Alexandre; Ayuso, Carmen; Reig, Maria.Referencia:Abdominal Radiology 2026.
-
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
Rimassa, Lorenza; Chan, Stephen L; Sangro, Bruno; Lau, George; Kudo, Masatoshi;(...)Ran, Di; Xynos, Ioannis; Kurland, John F; Negro, Alejandra; Abou-Alfa, Ghassan K.Referencia:JOURNAL OF HEPATOLOGY 2025.
-
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy
Fortuny, Marta; da Fonseca, Leonardo G; Allaire, Manon; Sanchez, Rocio; Nault, Jean-Charles;(...)Lue, Alberto; Varela, Maria; Matilla, Ana; Fernandez, Javier; Reig, Maria.Referencia:LIVER INTERNATIONAL 2025.
-
Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes
Fortuny, Marta; Garcia-Calonge, Marta; Arrabal, Oscar; Sanduzzi-Zamparelli, Marco; Castano-Garcia, Andres;(...)Lorca, Rebeca; Rodriguez, Manuel; Torres, Ferran; Varela, Maria; Reig, Maria.Referencia:EUROPEAN JOURNAL OF CANCER 2025.
-
Evolving epidemiology of HCC in Spain
Rodriguez, Manuel; Chiminazzo, Valentina; Sala, Margarita; Pascual, Sonia; Roca, Maria Rosa Rota;(...)Bermudez-Ramos, Maria; Lue, Alberto; Molina, Esther; Macias-Rodriguez, Manuel Alberto; Varela, Maria.Referencia:JHEP Rep 2025.
-
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Lau, George; Abou-Alfa, Ghassan K; Cheng, Ann-Lii; Sukeepaisarnjaroen, Wattana; Kang, Yoon Koo;(...)He, Aiwu Ruth; Makowsky, Mallory; Gupta, Charu; Negro, Alejandra; Chan, Stephen L.Referencia:JOURNAL OF HEPATOLOGY 2025.
-
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma.
Reig Monzón; María;Referencia:JOURNAL OF HEPATOLOGY 2025.
